Form 4: Light & Wonder Director Kneeland Youngblood Reports Stock Unit Vesting
SEC Form 4 Filing
Director Kneeland Youngblood reports the vesting of restricted stock units into common stock of Light & Wonder, Inc.
Summary
- On June 10, 2024, Dr. Kneeland Youngblood, a director of Light & Wonder, Inc., reported the vesting of 2,093 restricted stock units.
- These units converted into 2,093 shares of common stock on a one-for-one basis.
- Following the transaction, Dr. Youngblood beneficially owns 26,005 shares of Light & Wonder common stock.
Sentiment
Score: 5
Explanation: This is a neutral event, simply reporting the vesting of stock units. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The vesting of stock units has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/10/2020 | Date of grant for the restricted stock units, one-fourth of which vested on June 10, 2024. |
| 06/10/2024 | Date of transaction: Vesting of 2,093 restricted stock units and conversion to common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.